No Evidence for Genetic Role of the Tumor Necrosis Factor Pathway in Parkinson's Disease
No Thumbnail Available
Authors
Shahkhali,Morvarid Ghamgosar;Liu,Lang;Somerville,Emma N.;Noyce,Alastair J.;Gan-Or,Ziv;Senkevich,Konstantin
Check for full-text access
Issue Date
2025
Type
Article
Language
Keywords
Alternative Title
Abstract
Tumor necrosis factor (TNF) inhibition is under investigation as a therapeutic strategy for Parkinson's disease (PD) and REM sleep behavior disorder (RBD), yet supporting genetic evidence is limited. We used Summary-data-based Mendelian Randomization (SMR) to test whether expression level of ten TNF-related genes were causally linked to PD risk, PD progression, or RBD risk. We also analyzed associations between common and rare variants in these genes, and performed pathway specific polygenic risk score analysis, with PD. Overall, our findings do not support a genetic link between the TNF signaling and PD or RBD, arguing against this pathway as a genetically validated therapeutic target.
Description
Citation
Publisher
License
Journal
medRxiv : the preprint server for health sciences